Skip to main content

Table 1 Patient characteristics according to iron deficiency anemia

From: Association between atopic disease and anemia in pediatrics: a cross-sectional study

 

Frequency (%)

Crude OR (95% CI)

P value

No anemia N = (827,124)

IDA

(N = 19,594)

Age

8.97 (5.16)a

5.98 (5.48)a

0.89 (0.89–0.89)

<.001

Sex

 Male

428,361 (51.79)

9253 (47.22)

1 [Reference]

 

 Female

398,763 (48.21)

10,341 (52.78)

1.20 (1.17–1.24)

<.001

Insurance Types

 Health insurance

806,892 (97.55)

19,054 (97.24)

1 [Reference]

 

 Medical aid

20,232 (2.45)

540 (2.76)

1.13 (1.04–1.23)

0.006

Systemic infection

 Meningitis

1645 (0.20)

130 (0.66)

3.35 (2.80–4.01)

<.001

 BJI

803 (0.10)

41 (0.21)

2.16 (1.58–2.96)

<.001

 Sepsis

3071 (0.37)

478 (2.44)

6.71 (6.09–7.40)

<.001

 HEP

2445 (0.30)

695 (3.55)

12.40 (11.39–13.51)

<.001

 CKD

57 (0.01)

26 (0.13)

19.28 (12.12–30.67)

<.001

Mental disorder

 Depression

3931 (0.48)

178 (0.91)

1.92 (1.65–2.23)

<.001

 Anxiety

6518 (0.79)

309 (1.58)

2.02 (1.80–2.26)

<.001

Chronic inflammation

 PUD

15,248 (1.84)

640 (3.27)

1.80 (1.66–1.95)

<.001

 COPD

12,650 (1.53)

422 (2.15)

1.42 (1.29–1.56)

<.001

 SLE

228 (0.03)

26 (0.13)

4.83 (3.22–7.25)

<.001

 RA

1454 (0.18)

96 (0.49)

2.80 (2.27–3.44)

<.001

 IBD

265 (0.03)

68 (0.35)

10.87 (8.32–14.19)

<.001

 Cancer

1147 (0.14)

133 (0.68)

4.92 (4.11–5.89)

<.001

 Medication

 Steroid

333,265 (40.29)

11,726 (59.84)

2.21 (2.15–2.27)

<.001

 Methotrexate

162 (0.02)

26 (0.13)

6.78 (4.48–10.27)

<.001

 Cyclosporine

302 (0.04)

29 (0.15)

4.07 (2.78–5.96)

<.001

  1. amean (standard deviation)
  2. IDA Iron deficiency anemia, BJI Bone and joint infection, HEP Hepatitis, CKD Chronic kidney disease, PUD Peptic ulcer disease, COPD Chronic obstructive pulmonary disease, SLE Systemic lupus erythematosus, RA Rheumatoid arthritis, IBD Irritable bowel disease